These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18414039)

  • 1. The tumor suppressor p53: cancer and aging.
    Feng Z; Hu W; Rajagopal G; Levine AJ
    Cell Cycle; 2008 Apr; 7(7):842-7. PubMed ID: 18414039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.
    Feng Z; Hu W; de Stanchina E; Teresky AK; Jin S; Lowe S; Levine AJ
    Cancer Res; 2007 Apr; 67(7):3043-53. PubMed ID: 17409411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment.
    Feng Z
    Cold Spring Harb Perspect Biol; 2010 Feb; 2(2):a001057. PubMed ID: 20182617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caloric restriction: is mammalian life extension linked to p53?
    Tucci P
    Aging (Albany NY); 2012 Aug; 4(8):525-34. PubMed ID: 22983298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative growth hormone/IGF-1 and mTOR signaling pathways as a target for aging and cancer prevention: do we really have an antiaging drug?
    Anisimov VN
    Interdiscip Top Gerontol; 2015; 40():177-88. PubMed ID: 25341521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interfaces between signal transduction pathways: IGF-1/mTor, p53 and the Parkinson Disease pathway.
    Levine AJ; Harris CR; Puzio-Kuter AM
    Oncotarget; 2012 Nov; 3(11):1301-7. PubMed ID: 23211569
    [No Abstract]   [Full Text] [Related]  

  • 7. The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein.
    Feng Z; Levine AJ
    Trends Cell Biol; 2010 Jul; 20(7):427-34. PubMed ID: 20399660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile fugue: p53 in aging, cancer and IGF signaling.
    Campisi J
    Nat Med; 2004 Mar; 10(3):231-2. PubMed ID: 14991040
    [No Abstract]   [Full Text] [Related]  

  • 9. Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration.
    Mazucanti CH; Cabral-Costa JV; Vasconcelos AR; Andreotti DZ; Scavone C; Kawamoto EM
    Curr Top Med Chem; 2015; 15(21):2116-38. PubMed ID: 26059361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense.
    Olovnikov IA; Kravchenko JE; Chumakov PM
    Semin Cancer Biol; 2009 Feb; 19(1):32-41. PubMed ID: 19101635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Arf/p53 activity in stem cells, aging and cancer.
    Carrasco-Garcia E; Moreno M; Moreno-Cugnon L; Matheu A
    Aging Cell; 2017 Apr; 16(2):219-225. PubMed ID: 28101907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin/IGF-1 and ROS signaling pathway cross-talk in aging and longevity determination.
    Papaconstantinou J
    Mol Cell Endocrinol; 2009 Feb; 299(1):89-100. PubMed ID: 19103250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the aging process by autophagy.
    Salminen A; Kaarniranta K
    Trends Mol Med; 2009 May; 15(5):217-24. PubMed ID: 19380253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of reproduction and longevity by nutrient-sensing pathways.
    Templeman NM; Murphy CT
    J Cell Biol; 2018 Jan; 217(1):93-106. PubMed ID: 29074705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factors, aging and age-related diseases.
    Balasubramanian P; Longo VD
    Growth Horm IGF Res; 2016 Jun; 28():66-8. PubMed ID: 26883276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TOR pathway comes of age.
    Stanfel MN; Shamieh LS; Kaeberlein M; Kennedy BK
    Biochim Biophys Acta; 2009 Oct; 1790(10):1067-74. PubMed ID: 19539012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved signaling pathways genetically associated with longevity across the species.
    Khan AH; Zou Z; Xiang Y; Chen S; Tian XL
    Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1745-1755. PubMed ID: 31109448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intake.
    Sharples AP; Hughes DC; Deane CS; Saini A; Selman C; Stewart CE
    Aging Cell; 2015 Aug; 14(4):511-23. PubMed ID: 25866088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways.
    Levine AJ; Feng Z; Mak TW; You H; Jin S
    Genes Dev; 2006 Feb; 20(3):267-75. PubMed ID: 16452501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical role of metabolic pathways in aging.
    Barzilai N; Huffman DM; Muzumdar RH; Bartke A
    Diabetes; 2012 Jun; 61(6):1315-22. PubMed ID: 22618766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.